CHEK2 and breast cancer: In contrast to the strong association we observed with CHEK2, we found no association with LoF variants in ATM. The upper bound of the CI for ER-positive disease excludes the reported OR in the BC Association Consortium study16 but not the OR reported in the CARRIERS study17.